Position in GERN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$18,492
-$29,286 QoQ
Shares Held
14,447
-60.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#199
of 258 holders
Holding Since
Sep 2021
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GERN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TWO SIGMA SECURITIES, LLC holds $22,483,013 across 103 Biotechnology names. GERN ranks #75 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5,761 | $3,592,213 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
5,585 | $1,681,252 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
17,689 | $1,317,476 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
2,219 | $1,191,492 | |
| 5 | INSM |
INSMED Inc
|
10,338 | $1,102,237 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
12,525 | $980,331 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
11,256 | $917,476 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
3,708 | $907,607 |
All Filings in GERN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,492 | 14,447 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $47,778 | 36,196 | Shares | Sole | 2026-02-17 | |
| 2024-09-30 | $72,117 | 15,885 | Shares | Sole | 2024-11-14 | |
| 2023-06-30 | $74,741 | 23,284 | Shares | Sole | 2023-08-14 | |
| 2022-09-30 | $38,717 | 16,546 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $25,571 | 16,498 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $85,308 | 62,727 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $17,633 | 14,454 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $15,501 | 11,315 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||